CN110938106A - Method for preparing obeticholic acid intermediate and obeticholic acid thereof - Google Patents

Method for preparing obeticholic acid intermediate and obeticholic acid thereof Download PDF

Info

Publication number
CN110938106A
CN110938106A CN201911181990.2A CN201911181990A CN110938106A CN 110938106 A CN110938106 A CN 110938106A CN 201911181990 A CN201911181990 A CN 201911181990A CN 110938106 A CN110938106 A CN 110938106A
Authority
CN
China
Prior art keywords
obeticholic acid
reaction
preparing
organic solvent
polar organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911181990.2A
Other languages
Chinese (zh)
Other versions
CN110938106B (en
Inventor
葛敏
胡春晨
李令超
李亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Zhengji Pharmaceutical Research Co Ltd
Original Assignee
Nanjing Zhengji Pharmaceutical Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Zhengji Pharmaceutical Research Co Ltd filed Critical Nanjing Zhengji Pharmaceutical Research Co Ltd
Priority to CN201911181990.2A priority Critical patent/CN110938106B/en
Publication of CN110938106A publication Critical patent/CN110938106A/en
Application granted granted Critical
Publication of CN110938106B publication Critical patent/CN110938106B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Abstract

The invention discloses a method for preparing an obeticholic acid intermediate and obeticholic acid thereof, wherein the obeticholic acid intermediate is prepared by taking 3A-hydroxy-6-vinyl-7-oxo-cholanic acid as a raw material through carbonyl reduction and hydroxy protection, the obtained obeticholic acid intermediate contains two benzene ring structures, has strong ultraviolet absorption, and is convenient for using an ultraviolet detector to carry out quality research, so that the quality of the raw material in the last step is ensured to be controllable, and the raw material is in a solid state at room temperature and can be refined by conventional purification means such as recrystallization and the like; and then, the obeticholic acid is obtained by further using palladium-carbon reduction, and the reduction of an olefinic bond is completed firstly in the palladium-carbon reduction process from the reaction process, so that the tracking reaction is convenient, the reaction yield is high, the conversion is complete, and the refining difficulty of the final product is reduced.

Description

Method for preparing obeticholic acid intermediate and obeticholic acid thereof
Technical Field
The invention relates to the technical field of drug synthesis, in particular to a method for preparing an obeticholic acid intermediate and obeticholic acid thereof.
Background
Obeticholic acid has attracted considerable attention because of its excellent therapeutic effects on a variety of chronic liver diseases, including Primary Biliary Cirrhosis (PBC), nonalcoholic steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), and biliary atresia. The structure is as follows:
Figure BDA0002291516360000011
in 2002, WO2002072598 discloses a synthetic route of obeticholic acid for the first time, and as shown in the following, a compound II reacts with iodoethane under a strong alkaline condition to obtain a compound III, and then the compound III is subjected to reduction hydrolysis to obtain a target compound I. The synthesis line is simple, but the alkylation directly using iodoethane has more side reactions, and the yield is low, so that the method is not suitable for large-scale production.
Figure BDA0002291516360000012
WO2006122977 improves the synthesis process, and converts a compound V with trimethylsilyl protecting group into a silyl enol ether compound VI under the strong alkali condition, the compound VI reacts with Mukaiyama aldol between acetaldehyde to obtain a compound VII, the compound VII is subjected to hydrogenation reduction by palladium carbon and then epimerization to obtain a compound VIII, and finally, the compound VIII is subjected to reduction carbonyl to obtain obeticholic acid I. The process route has the defects that the compound VII adopts high temperature (90-105 ℃) and strong base (30% of caustic soda) in the hydrogenation process of palladium carbon, and the safety problem is a great challenge besides side reaction elimination easily occurs.
Figure BDA0002291516360000021
WO2016045480 takes a compound IX as a raw material, and obtains a target compound I through hydroxyl protection, palladium-carbon hydrogenation, carbonyl reduction and deprotection, thereby avoiding hydrogenation conditions of high temperature and strong base. However, the route adopts an ethyl ester compound as a starting material, which is not beneficial to the initial quality control, and adopts-MOM as a hydroxyl protecting group, and related intermediates mostly exist in an oily form, so that the quality control in the process of scale-up production is difficult to realize.
Figure BDA0002291516360000022
Disclosure of Invention
The purpose of the invention is as follows: the invention aims to provide a method for preparing an obeticholic acid intermediate and obeticholic acid thereof, which is used for preparing obeticholic acid by taking a compound XIII (3A-hydroxy-6-vinyl-7-oxo-cholanic acid) as a raw material through reduction, hydroxy protection and reduction synthesis, and solves the problems of more side reactions, low yield and unsuitability for large-scale production in the conventional production method. The raw materials are white solids, are easy to obtain in the market, are convenient for quality control, have mild reaction and few byproducts, and are suitable for large-scale production of obeticholic acid.
The technical scheme is as follows: the invention relates to a method for preparing an obeticholic acid intermediate, which is shown in a formula XV, and the synthetic route is as follows:
Figure BDA0002291516360000031
in the formula, Bn is benzyl; the specific reaction conditions are as follows:
and (3) carbonyl reduction reaction: dissolving 3A-hydroxy-6-vinyl-7-oxo-cholanic acid and borohydride shown in a general formula XIII in a polar organic solvent 1, mixing and reacting at the temperature of 10-40 ℃ for 8-16 h, quenching after the reaction is finished, extracting and separating, and concentrating to obtain an intermediate XIV;
hydroxyl protection reaction: dissolving the intermediate XIV in a polar organic solvent 2, mixing and reacting with benzyl halide under an alkaline condition, wherein the reaction temperature is 40-60 ℃, the reaction time is 8-16 h, cooling after the reaction is finished, adding toluene and a 5% acetic acid aqueous solution, stirring for layering, and concentrating to obtain an intermediate XV.
Further, the polar organic solvent 1 is selected from methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran or a mixture thereof, and the borohydride salt is selected from potassium borohydride, sodium borohydride or a mixture thereof.
Further, the polar organic solvent 2 is selected from N, N-dimethylformamide, pyridine, methanol, ethanol, tetrahydrofuran or a mixture thereof, and the alkaline substance is selected from one of sodium hydroxide, potassium hydroxide, sodium alkoxide, potassium alkoxide, sodium carbonate, potassium carbonate or ammonium hydroxide.
Further, the amount of the basic substance added under the basic condition is 1 to 3 times of the molar amount of the compound XIV.
The invention also discloses a method for preparing obeticholic acid, which comprises the following synthetic route:
Figure BDA0002291516360000032
wherein Bn is benzyl, comprising the following steps:
1) reduction reaction of palladium on carbon: dissolving an obeticholic acid intermediate XV in a polar organic solvent 3, reacting at 20-40 ℃ under the relative pressure of 0.5-1.5 MPa by using hydrogen as a hydrogen source and Pd/C as a catalyst under an alkaline condition, and preserving heat for hydrogenation until the hydrogen is not absorbed any more;
2) and (3) collecting obeticholic acid: after the reaction is finished, the obeticholic acid is obtained after separation and purification.
6. The method for preparing obeticholic acid according to claim 5, characterized in that: the obeticholic acid intermediate XV is prepared by the method of any one of claims 1 to 4.
Further, the alkaline substance under alkaline conditions is selected from one of sodium hydroxide, potassium hydroxide, sodium alkoxide, potassium alkoxide, sodium carbonate, potassium carbonate or ammonium hydroxide.
Further, the polar organic solvent 3 is selected from methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran or a mixture thereof.
Furthermore, the molar weight of the basic substance compound is 1-3 times of the molar weight of the obeticholic acid intermediate XV.
The invention has the following beneficial effects:
(1) the starting material compound XIII is purchased in the market, and the market can provide a large amount of raw materials with maximum single impurity less than 0.5% and purity more than 98%;
(2) the compound XV contains two benzene ring structures, has strong ultraviolet absorption, is convenient for using an ultraviolet detector to carry out quality research, thereby ensuring that the quality of the raw material in the last step is controllable, is in a solid state at room temperature, and can be refined by conventional purification means such as recrystallization and the like;
(3) and the final step adopts palladium-carbon reduction, the reduction of the olefinic bond is completed firstly in the reaction process, the tracking reaction is convenient, the reaction yield is high, the conversion is complete, and the refining difficulty of the final product is reduced.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
The invention is further described below with reference to examples:
example 1
Carbonyl reduction reaction
Preparation of Compound XIV
Figure BDA0002291516360000041
Adding 20ml of ethanol and 4.2g of compound XIII into a 100ml round-bottom flask in sequence, stirring and dissolving the solution, adding 0.95g of sodium borohydride in batches at 10 ℃, reacting for 8 hours fully, adding acetic acid to quench the reaction after the reaction is finished, adding toluene and water, stirring and layering, removing the water phase, washing the organic phase once with 5% acetic acid water solution, drying, and spin-drying to obtain the crude compound XIV which is directly used for the next reaction with the yield of 100%.
Example 2
Hydroxyl radical protection reaction
Preparation of Compound XV
Figure BDA0002291516360000051
A100 ml round bottom flask was charged with the crude compound XIV prepared in example 1 and completely dissolved in N, N-dimethylformamide, and then 0.46g of potassium carbonate was added, and finally 3.4g of benzyl bromide was added, heated to 40 deg.C, stirred and reacted for 8 hours, cooled after the reaction was completed, and then toluene and a 5% aqueous solution of acetic acid were added, stirred and layered, the aqueous phase was removed, the organic phase was dried and then spun dry, and recrystallized from toluene to obtain 5.5g of intermediate XV refined product, with a yield of 92%.
Example 3
Reduction reaction of palladium on carbon
Preparation of obeticholic acid I
Figure BDA0002291516360000052
1) Adding 3.0g of compound XV, 50ml of methanol, 0.005g of 10% Pd/C, 0.02g of sodium hydroxide and 100ml of water into a 100ml hydrogenation kettle in sequence, sealing the hydrogenation kettle after the mixture is uniformly stirred, and sequentially using N2And H2Replacing air in the system, controlling the temperature at 20 ℃, controlling the hydrogen pressure at 0.5MPa, and reacting the mixture system for 2 hours under stirring;
2) termination of the reaction, using N in succession2And air displacement system H2
3) And filtering the mixture to separate Pd/C, removing the solvent by spinning to obtain a crude product of obeticholic acid, and crystallizing and purifying the obeticholic acid by ethyl acetate to obtain a refined product of 1.8g, wherein the yield is 85%.
Example 4
Carbonyl reduction reaction
Preparation of Compound XIV
Figure BDA0002291516360000061
Adding 20ml of ethanol and 4.2g of compound XIII into a 100ml round-bottom flask in sequence, stirring and dissolving the solution clearly, adding 0.95g of sodium borohydride in batches at 40 ℃, reacting for 16 hours fully, adding acetic acid to quench the reaction after the reaction is finished, adding toluene and water, stirring and layering, removing the water phase, washing the organic phase once with 5% acetic acid water solution, drying, and spin-drying to obtain the crude product of compound XIV which is directly used for the next reaction with the yield of 100%.
Example 5
Hydroxyl radical protection reaction
Preparation of Compound XV
Figure BDA0002291516360000062
A100 ml round bottom flask was charged with the crude compound XIV prepared in example 1 and completely dissolved in N, N-dimethylformamide, and then 0.46g of potassium carbonate was added, and finally 3.4g of benzyl bromide was added, heated to 60 deg.C, stirred and reacted for 16 hours, cooled after the reaction was completed, and then toluene and a 5% aqueous solution of acetic acid were added, stirred and layered, the aqueous phase was removed, the organic phase was dried and then spun dry, and recrystallized from toluene to obtain 5.5g of intermediate XV refined product, with a yield of 92%.
Example 6
Reduction reaction of palladium on carbon
Preparation of obeticholic acid I
Figure BDA0002291516360000071
1) Adding 3.0g of compound XV, 50ml of methanol, 0.05g of 10% Pd/C, 0.01g of sodium hydroxide and 100ml of water into a 100ml hydrogenation kettle in sequence, sealing the hydrogenation kettle after the mixture is uniformly stirred, and sequentially using N2And H2Replacing air in the system, controlling the temperature at 40 ℃, controlling the hydrogen pressure at 1.5MPa, and reacting the mixture system for 3 hours under stirring;
2) termination of the reaction, using N in succession2And air displacement system H2
3) And filtering the mixture to separate Pd/C, removing the solvent by spinning to obtain a crude product of obeticholic acid, and crystallizing and purifying the obeticholic acid by ethyl acetate to obtain a refined product of 1.8g, wherein the yield is 85%.
Example 7
Preparation of obeticholic acid I
Figure BDA0002291516360000072
1) And (3) carbonyl reduction reaction: adding 20ml of polar organic solvent ethanol and 4.2g of compound XIII into a 100ml round-bottom flask in sequence, stirring and dissolving the solution clearly, adding 0.95g of sodium borohydride in batches at 30 ℃, fully reacting for 12 hours, adding acetic acid to quench the reaction after the reaction is finished, adding toluene and water, stirring and layering to remove the water phase, washing the organic phase once with 5% acetic acid water solution, drying, and spin-drying to obtain the crude compound XIV which is directly used for the next reaction with the yield of 100%.
Experiments show that the polar organic solvent is methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran or a mixture thereof, and has no fundamental influence on the reaction result; the borohydride is potassium borohydride, sodium borohydride or a mixture thereof, and has no fundamental influence on the reaction result;
2) hydroxyl protection reaction: adding the crude compound XIV prepared in the step 1) into a 100ml round-bottom flask, completely dissolving the crude compound XIV into a polar organic solvent N, N-dimethylformamide, adding 0.46g of alkaline substance potassium carbonate, finally adding 3.4g of benzyl bromide, heating to 50 ℃, stirring for reaction for 12 hours, cooling after the reaction is finished, adding toluene and a 5% acetic acid aqueous solution, stirring for layering, removing an aqueous phase, drying an organic phase in a spinning mode after drying, recrystallizing with toluene to obtain 5.5g of an intermediate XV refined product, wherein the yield is 92%;
experiments show that the polar organic solvent is N, N-dimethylformamide, pyridine, methanol, ethanol, tetrahydrofuran or a mixture thereof, and has no obvious influence on experimental results; the alkaline substance is selected from one of sodium hydroxide, potassium hydroxide, sodium alkoxide, potassium alkoxide, sodium carbonate, potassium carbonate or ammonium hydroxide, and has no fundamental influence on the reaction result;
3) reduction reaction of palladium on carbon: adding 3.0g of compound XV, 50ml of polar organic solvent methanol, 0.015g of 10% Pd/C, 0.02g of sodium hydroxide and 50ml of water into a 500ml hydrogenation kettle in sequence, sealing the hydrogenation kettle after the mixture is uniformly stirred, and sequentially using N2And H2Replacing air in the system, controlling the temperature at 30 ℃ and the hydrogen pressure at 1.0MPa, reacting the mixture system for 2 hours under stirring, terminating the reaction, and sequentially using N2And air displacement system H2Filtering the obtained mixture to separate Pd/C, removing the solvent by spinning to obtain a crude product of obeticholic acid, and crystallizing and purifying the obeticholic acid by ethyl acetate to obtain a refined product of 1.8g with the yield of 85%;
experiments show that the polar organic solvent is selected from alcohol, ethanol, n-propanol, isopropanol, tetrahydrofuran or a mixture thereof, and has no obvious influence on experimental results; the alkaline substance is selected from one of sodium hydroxide, potassium hydroxide, sodium alkoxide, potassium alkoxide, sodium carbonate, potassium carbonate or ammonium hydroxide, and has no fundamental influence on the reaction result.

Claims (9)

1. A method of preparing an obeticholic acid intermediate, characterized by: the structural general formula of the intermediate is shown as formula XV, and the synthetic route is as follows:
Figure FDA0002291516350000011
in the formula, Bn is benzyl; the specific reaction conditions are as follows:
and (3) carbonyl reduction reaction: dissolving 3A-hydroxy-6-vinyl-7-oxo-cholanic acid and borohydride shown in a general formula XIII in a polar organic solvent 1, mixing and reacting at the temperature of 10-40 ℃ for 8-16 h, quenching after the reaction is finished, extracting and separating, and concentrating to obtain an intermediate XIV;
hydroxyl protection reaction: dissolving the intermediate XIV in a polar organic solvent 2, mixing and reacting with benzyl halide under an alkaline condition, wherein the reaction temperature is 40-60 ℃, the reaction time is 8-16 h, cooling after the reaction is finished, adding toluene and a 5% acetic acid aqueous solution, stirring for layering, and concentrating to obtain an intermediate XV.
2. The method for preparing obeticholic acid intermediate according to claim 1, characterized in that: the polar organic solvent 1 is selected from methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran or a mixture thereof, and the borohydride salt is selected from potassium borohydride, sodium borohydride or a mixture thereof.
3. The method for preparing obeticholic acid intermediate according to claim 1, characterized in that: the polar organic solvent 2 is selected from N, N-dimethylformamide, pyridine, methanol, ethanol, tetrahydrofuran or a mixture thereof, and the alkaline substance is selected from one of sodium hydroxide, potassium hydroxide, sodium alkoxide, potassium alkoxide, sodium carbonate, potassium carbonate or ammonium hydroxide.
4. The method for preparing obeticholic acid intermediate according to claim 1, characterized in that: the addition amount of the alkaline substance under the alkaline condition is 1-3 times of the molar weight of the compound XIV.
5. The method for preparing obeticholic acid is characterized in that the synthetic route is as follows:
Figure FDA0002291516350000012
wherein Bn is benzyl, comprising the following steps:
1) reduction reaction of palladium on carbon: dissolving an obeticholic acid intermediate XV in a polar organic solvent 3, reacting at 20-40 ℃ under the relative pressure of 0.5-1.5 MPa by using hydrogen as a hydrogen source and Pd/C as a catalyst under an alkaline condition, and preserving heat for hydrogenation until the hydrogen is not absorbed any more;
2) and (3) collecting obeticholic acid: after the reaction is finished, the obeticholic acid is obtained after separation and purification.
6. The method for preparing obeticholic acid according to claim 5, characterized in that: the obeticholic acid intermediate XV is prepared by the method of any one of claims 1 to 4.
7. The method for preparing obeticholic acid according to claim 5, characterized in that: the alkaline substance under the alkaline condition is selected from one of sodium hydroxide, potassium hydroxide, sodium alkoxide, potassium alkoxide, sodium carbonate, potassium carbonate or ammonium hydroxide.
8. The method for preparing obeticholic acid according to claim 5, characterized in that: the polar organic solvent 3 is selected from methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran or a mixture thereof.
9. The method for preparing obeticholic acid according to claim 7, characterized in that: the molar weight of the basic substance compound is 1-3 times of the molar weight of the intermediate XV of the obeticholic acid.
CN201911181990.2A 2019-11-27 2019-11-27 Method for preparing obeticholic acid intermediate and obeticholic acid thereof Active CN110938106B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911181990.2A CN110938106B (en) 2019-11-27 2019-11-27 Method for preparing obeticholic acid intermediate and obeticholic acid thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911181990.2A CN110938106B (en) 2019-11-27 2019-11-27 Method for preparing obeticholic acid intermediate and obeticholic acid thereof

Publications (2)

Publication Number Publication Date
CN110938106A true CN110938106A (en) 2020-03-31
CN110938106B CN110938106B (en) 2021-06-04

Family

ID=69908553

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911181990.2A Active CN110938106B (en) 2019-11-27 2019-11-27 Method for preparing obeticholic acid intermediate and obeticholic acid thereof

Country Status (1)

Country Link
CN (1) CN110938106B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021109883A1 (en) * 2019-12-04 2021-06-10 博瑞生物医药(苏州)股份有限公司 Method for use in preparing obeticholic acid

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646633A (en) * 2016-01-22 2016-06-08 南京长澳医药科技有限公司 Method for preparing obeticholic acid type 1
CN106083970A (en) * 2016-05-31 2016-11-09 北京康立生医药技术开发有限公司 A kind of synthetic method of cholanic acid
CN107383139A (en) * 2017-08-09 2017-11-24 杭州和泽医药科技有限公司 The method that a kind of β cholanic acid new derivatives of 7 oxo of 3 α hydroxyls 5 prepare shellfish cholic acid difficult to understand
WO2017207648A1 (en) * 2016-05-31 2017-12-07 Bionice, S.L.U Process and intermediates for the preparation of obeticholic acid and derivatives thereof
CN107663221A (en) * 2016-07-27 2018-02-06 南京长澳医药科技有限公司 A kind of preparation method of shellfish cholic acid difficult to understand
CN109311933A (en) * 2016-04-04 2019-02-05 迪法玛弗朗西斯有限公司 The method for preparing farnesol X receptor stimulating agent

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646633A (en) * 2016-01-22 2016-06-08 南京长澳医药科技有限公司 Method for preparing obeticholic acid type 1
CN109311933A (en) * 2016-04-04 2019-02-05 迪法玛弗朗西斯有限公司 The method for preparing farnesol X receptor stimulating agent
CN106083970A (en) * 2016-05-31 2016-11-09 北京康立生医药技术开发有限公司 A kind of synthetic method of cholanic acid
WO2017207648A1 (en) * 2016-05-31 2017-12-07 Bionice, S.L.U Process and intermediates for the preparation of obeticholic acid and derivatives thereof
CN107663221A (en) * 2016-07-27 2018-02-06 南京长澳医药科技有限公司 A kind of preparation method of shellfish cholic acid difficult to understand
CN107383139A (en) * 2017-08-09 2017-11-24 杭州和泽医药科技有限公司 The method that a kind of β cholanic acid new derivatives of 7 oxo of 3 α hydroxyls 5 prepare shellfish cholic acid difficult to understand

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROBERTO PELLICCIARI 等: "Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators", 《ACS MEDICINAL CHEMISTRY LETTERS》 *
向文胜、王相晶主编: "《仪器分析》", 31 December 2006 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021109883A1 (en) * 2019-12-04 2021-06-10 博瑞生物医药(苏州)股份有限公司 Method for use in preparing obeticholic acid

Also Published As

Publication number Publication date
CN110938106B (en) 2021-06-04

Similar Documents

Publication Publication Date Title
WO2021258723A1 (en) Method for synthesizing lithocholic acid with ba as raw material
CN112062805B (en) High-efficiency delta9,11Process for the preparation of (E) -canrenone
CN110938106B (en) Method for preparing obeticholic acid intermediate and obeticholic acid thereof
CN109096122B (en) Process for preparing spermidine
CN107298694A (en) The synthetic method and its intermediate of shellfish cholic acid difficult to understand
CN112062669A (en) Process for preparing aromatic compounds
CN105566223A (en) Crude iminostilbene product recrystallization method
CN114702425A (en) Preparation method of (S) -2-amino- (S) -3- [ pyrrolidone-2' ] alanine derivative and intermediate
CN105439837B (en) Synthetic method of 6-bromoisovanillin
CN114920698A (en) Preparation method of 6-chloro-2-methyl-2H-indole-5-amine
CN111018928B (en) Synthetic method and application of gastrodin hemihydrate
CN109651234B (en) Synthesis method of donepezil hydrochloride
CN107383137A (en) A kind of synthetic method of chenodeoxycholic acid
CN108203396B (en) Synthesis of enkephalinase inhibitor
CN115536494B (en) Synthesis method of 1- (4-bromophenyl) -1, 4-butanediol
CN115073313B (en) Method for synthesizing terbutaline sulfate impurity C
CN112694436B (en) Method for synthesizing arecoline
CN113024624A (en) Synthetic method of deoxycholic acid
CN115677456B (en) Preparation method of cannabidiol
CN110818679B (en) Synthetic method of 4-bromobenzo [ b ] thiophene
CN111039838B (en) Preparation method of 3-acetylmercapto-2-methylpropanoic acid
CN103319373B (en) The preparation method of 1 [2 amino 1 (4 benzyloxy-phenyl) ethyl] hexamethylene alkanol and related intermediate
CN108239134B (en) Obeticholic acid intermediate and preparation method and application thereof
CN107793463A (en) A kind of preparation method of the acid of 3 α hydroxyls, 6 α ethyls, 7 ketone, 5 β courages 24
CA2742740C (en) A process for manufacturing zeranol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant